Corcept Therapeutics competitorsClear all

Corcept Therapeutics's top competitors include Insys Therapeutics, ASLAN Pharmaceuticals, Shanghai Henlius Biotech and Xencor.
Corcept Therapeutics
Corcept Therapeutics
Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders.
Insys Therapeutics
Insys Therapeutics
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products.
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
Shanghai Henlius Biotech
Shanghai Henlius Biotech
Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.
Xencor
Xencor
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
Founding Date
Founding Date
1998
Founding Date
1998
Founding Date
N/A
Founding Date
2009
Founding Date
1997
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Chandler, US HQ
Round Rock, US
Chandler, US
Locations
Singapore, SG HQ
Collingwood, AU
Pudong Xinqu, CN
Xinyi District, TW
Locations
HQ
Locations
Monrovia, US HQ
San Diego, US
Employees
Employees
16622% increase
Employees
22634% decrease
Employees
46
Employees
1273% increase
Employees
15637% increase
Valuation ($)
Valuation ($)
1.2 b
Valuation ($)
47.4 m
Valuation ($)
112.5 m
Valuation ($)
N/A
Valuation ($)
1.7 b
Alexa Website Rank
Alexa Website Rank
1121653
Alexa Website Rank
658340
Alexa Website Rank
638510
Alexa Website Rank
316491
Alexa Website Rank
676256

Financial

Cost of goods
Cost of goods
$5.2m (FY, 2018)
Cost of goods
$10.8m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Net income
Net income
$75.4m (FY, 2018)
Net income
($124.5m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
($70.4m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 80.1m
Total funding raised
$ 2.3m
Total funding raised
$ 100m
Total funding raised
$ 346m
Total funding raised
$ 108.4m
For sources of this data, please see the company profile

View company profiles

Insys Therapeutics
HQ
Chandler, US
Employees
226↓ 34% decrease

Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products.

View company
ASLAN Pharmaceuticals
HQ
Singapore, SG
Employees
46

ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.

View company
Shanghai Henlius Biotech
HQ
Employees
127↑ 3% increase

Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services.

View company
Xencor
HQ
Monrovia, US
Employees
156↑ 37% increase

Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.

View company